Jonathan Wong
The Latest
-
Frontier Airlines Launches $299 All-You-Can-Fly Annual Pass for 2025 Travelers
Frontier Airlines has announced its boldest travel deal yet: a $299 all-you-can-fly annual pass, offering budget-conscious travelers the opportunity to explore unlimited destinations across the United States, the Caribbean, Mexico, and Latin America. Dubbed the "GoWild!" pass, the deal is available as a limited-time pre-sale for the first 5,000 customers, with the price increasing to $499 once the initial batch is sold. 
Frontier Airlines has announced its boldest travel deal yet: a $299 all-you-can-fly annual pass, offering budget-conscious travelers the opportunity to explore unlimited destinations across the United States, the Caribbean, Mexico, and Latin America. Dubbed the "GoWild!" pass, the deal is available as a limited-time pre-sale for the first 5,000 customers, with the price increasing to $499 once the initial batch is sold. -
Merck Enters $2 Billion Deal for Oral Weight Loss Drug with Chinese Biotech Hansoh
Merck & Co. has secured a licensing agreement with Chinese drugmaker Hansoh Pharma for an experimental oral weight-loss drug, marking its latest foray into the burgeoning obesity treatment market. The deal, announced Wednesday, could be worth up to $2 billion, with Merck betting on the potential of Hansoh's preclinical drug, HS-10535, to compete with existing blockbuster injectable treatments. 
Merck & Co. has secured a licensing agreement with Chinese drugmaker Hansoh Pharma for an experimental oral weight-loss drug, marking its latest foray into the burgeoning obesity treatment market. The deal, announced Wednesday, could be worth up to $2 billion, with Merck betting on the potential of Hansoh's preclinical drug, HS-10535, to compete with existing blockbuster injectable treatments. -
CFPB Launches Consumer Tool Amid Warnings of Credit Card Rewards Scams and High Fees
The Consumer Financial Protection Bureau (CFPB) has issued a warning to credit card companies about deceptive practices that harm consumers, especially during the holiday shopping season. The agency has accused some issuers of manipulating rewards programs, devaluing points or miles, and creating unnecessary obstacles for consumers attempting to redeem their earned rewards. These practices, often buried in fine print, have prompted the CFPB to launch new initiatives to protect consumers and enhance transparency. 
The Consumer Financial Protection Bureau (CFPB) has issued a warning to credit card companies about deceptive practices that harm consumers, especially during the holiday shopping season. The agency has accused some issuers of manipulating rewards programs, devaluing points or miles, and creating unnecessary obstacles for consumers attempting to redeem their earned rewards. These practices, often buried in fine print, have prompted the CFPB to launch new initiatives to protect consumers and enhance transparency. -
Honda and Nissan Reportedly in Merger Talks to Form Global Automotive Powerhouse
Japanese automakers Honda Motor Co. and Nissan Motor Co. are reportedly preparing to enter merger negotiations in an effort to bolster their competitiveness amid mounting pressure in the global automotive industry. According to a report from Nikkei Asia, the two companies aim to form a unified entity under a holding company structure, potentially incorporating Mitsubishi Motors-in which Nissan already holds a 24% stake. 
Japanese automakers Honda Motor Co. and Nissan Motor Co. are reportedly preparing to enter merger negotiations in an effort to bolster their competitiveness amid mounting pressure in the global automotive industry. According to a report from Nikkei Asia, the two companies aim to form a unified entity under a holding company structure, potentially incorporating Mitsubishi Motors-in which Nissan already holds a 24% stake. -
Pfizer Projects Stable 2025 Earnings Despite $1 Billion Hit from Medicare Changes, Shares Rise
Pfizer Inc. offered a cautiously optimistic forecast for 2025 on Tuesday, predicting adjusted profits that align with Wall Street expectations and signaling stability despite mounting investor pressure and regulatory hurdles. The pharmaceutical giant's outlook, which included steady revenues for its COVID-19 products, helped its shares rise by approximately 4% in early trading. 
Pfizer Inc. offered a cautiously optimistic forecast for 2025 on Tuesday, predicting adjusted profits that align with Wall Street expectations and signaling stability despite mounting investor pressure and regulatory hurdles. The pharmaceutical giant's outlook, which included steady revenues for its COVID-19 products, helped its shares rise by approximately 4% in early trading. -
Alibaba Sells Intime Retail for $1 Billion, Recording $1.3 Billion Loss
Alibaba Group Holding is set to exit its physical retail business after announcing plans to sell its entire stake in Intime Retail Group for $1 billion, marking a $1.3 billion loss on the deal. The Chinese e-commerce giant's decision reflects its strategic shift to refocus on its core online commerce operations amid mounting competition and challenging market conditions. 
Alibaba Group Holding is set to exit its physical retail business after announcing plans to sell its entire stake in Intime Retail Group for $1 billion, marking a $1.3 billion loss on the deal. The Chinese e-commerce giant's decision reflects its strategic shift to refocus on its core online commerce operations amid mounting competition and challenging market conditions. -
SoftBank CEO and Trump Unveil $100 Billion Investment Targeting U.S. AI Growth
SoftBank CEO Masayoshi Son joined President-elect Donald Trump on Monday at Trump's Mar-a-Lago residence in Florida to unveil a $100 billion investment initiative aimed at bolstering the U.S. economy. The plan, spanning four years, is set to focus on artificial intelligence and related infrastructure, promising to create at least 100,000 jobs during Trump's upcoming term. 
SoftBank CEO Masayoshi Son joined President-elect Donald Trump on Monday at Trump's Mar-a-Lago residence in Florida to unveil a $100 billion investment initiative aimed at bolstering the U.S. economy. The plan, spanning four years, is set to focus on artificial intelligence and related infrastructure, promising to create at least 100,000 jobs during Trump's upcoming term. -
Europe Launches $11 Billion IRIS² Satellite Constellation to Challenge Starlink
The European Union has officially launched its ambitious IRIS² satellite project, a $11 billion initiative aimed at securing Europe's digital and strategic autonomy in the increasingly competitive satellite communication space. This public-private collaboration seeks to establish a European counterpart to Elon Musk's Starlink, addressing the need for secure, high-speed internet access and resilient communication networks across the continent. 
The European Union has officially launched its ambitious IRIS² satellite project, a $11 billion initiative aimed at securing Europe's digital and strategic autonomy in the increasingly competitive satellite communication space. This public-private collaboration seeks to establish a European counterpart to Elon Musk's Starlink, addressing the need for secure, high-speed internet access and resilient communication networks across the continent. -
Broadcom Reaches $1 Trillion Valuation Amid Explosive AI Revenue Growth
Broadcom Inc. achieved a historic milestone on Friday, surpassing a $1 trillion market capitalization for the first time following a robust earnings report that underscored its dominance in the artificial intelligence (AI) chip market. Shares of the semiconductor giant soared more than 21%, marking its largest single-day gain since March 2020. 
Broadcom Inc. achieved a historic milestone on Friday, surpassing a $1 trillion market capitalization for the first time following a robust earnings report that underscored its dominance in the artificial intelligence (AI) chip market. Shares of the semiconductor giant soared more than 21%, marking its largest single-day gain since March 2020. -
UnitedHealth Group CEO Calls U.S. Healthcare System ‘Flawed’ After Colleague’s Tragic Murder
UnitedHealth Group CEO Andrew Witty, in his first public comments since the fatal shooting of Brian Thompson, acknowledged the flaws in the U.S. healthcare system while paying tribute to his late colleague. Thompson, who led UnitedHealthcare, the largest private insurer in the U.S., was killed on December 4 in midtown Manhattan, a tragedy that has amplified frustrations over the state of healthcare. 
UnitedHealth Group CEO Andrew Witty, in his first public comments since the fatal shooting of Brian Thompson, acknowledged the flaws in the U.S. healthcare system while paying tribute to his late colleague. Thompson, who led UnitedHealthcare, the largest private insurer in the U.S., was killed on December 4 in midtown Manhattan, a tragedy that has amplified frustrations over the state of healthcare.
